COMBINATION BIOLOGIC THERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA IN THE OUTPATIENT TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

被引：0
|
作者：
FIGLIN, RA [1 ]
PIERCE, WC [1 ]
BELLDEGRUN, A [1 ]
机构：
[1] UNIV CALIF LOS ANGELES, SCH MED,JONSSON COMPREHENS CANC CTR,DEPT SURG, DIV UROL, LOS ANGELES, CA 90024 USA
来源：
SEMINARS IN ONCOLOGY | 1993年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 15
页数：5
相关论文
共 50 条
  • [21] RECOMBINANT INTERFERON-ALPHA-2A AND INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    JURINCICWINKLER, C
    HORLBECK, R
    KLIPPEL, KF
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (10) : 271 - 276
  • [22] LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA
    STADLER, WM
    VOGELZANG, NJ
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 67 - 73
  • [23] EUROPEAN STUDIES OF INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA
    ATZPODIEN, J
    KIRCHNER, H
    HANNINEN, EL
    KORFER, A
    FENNER, M
    MENZEL, T
    DECKERT, M
    FRANZKE, A
    JONAS, U
    POLIWODA, H
    SEMINARS IN ONCOLOGY, 1993, 20 (06) : 22 - 26
  • [24] EFFECT OF COMBINATION TREATMENT WITH INTERLEUKIN-2 AND RADIATION FOR MURINE RENAL-CELL CARCINOMA
    ONISHI, T
    MACHIDA, T
    IIZUKA, N
    SHIRAKAWA, H
    HATANO, T
    MAKINO, H
    SAWADA, T
    CANCER JOURNAL - FRANCE, 1992, 5 (04): : 230 - 234
  • [25] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Johannes Vieweg
    Nature Clinical Practice Oncology, 2005, 2 : 192 - 193
  • [26] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [27] Bevacizumab in combination with interferon-alfa for metastatic renal cell carcinoma: Tolerability and safety in daily practice
    Soetekouw P.M.M.B.
    Beeker A.
    Bex A.
    Van Groeningen C.J.
    Mulders P.F.A.
    Tijdschrift voor Urologie, 2011, 1 (8) : 170 - 177
  • [28] Retrospective analysis of interferon-alfa, interleukin-2 and 5-fluorouracyl based chemioimmunotherapy in treatment of patients with metastatic renac cell carcinoma
    Zolnierek, Jakub
    Nurzynski, Pawel
    Obrocka, Beata
    Lesniewski-Kmak, Krzysztof
    Korniluk, Jan
    Szczylik, Cezary
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (03): : 92 - 94
  • [29] Sunitinib versus interferon - alfa in metastatic renal-cell carcinoma
    Irani, Jacques
    PROGRES EN UROLOGIE, 2007, 17 (05): : 996 - 996
  • [30] Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: Results of a sequential nonrandomized-phase II study
    Tourani, JM
    Pfister, C
    Berdah, JF
    Benhammouda, A
    Salze, P
    Monnier, A
    Paule, B
    Guillet, P
    Chretien, Y
    Brewer, Y
    Di Palma, M
    Untereiner, M
    Malaurie, E
    Tadrist, Z
    Pavlovitch, JM
    Hauteville, D
    Mejean, A
    Azagury, M
    Mayeur, D
    Lucas, V
    Krakowski, I
    Larregain-Fournier, D
    Abourachid, H
    Andrieu, JM
    Chastang, C
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) : 2505 - 2513
12345